Ayala Cmm, Ayala LG, Vizmanos LB, Andrade VJ

Language: Spanish
References: 18
Page: 5-9
PDF size: 77.74 Kb.

ABSTRACT

Cervical neoplasia and infection with Human Immunodeficiency Virus (HIV) represent serious health problems of people around the world, mainly in developing countries like Mexico. Objectives: To identify abnormal colposcopic findings in women with HIV at the Hospital Civil de Guadalajara "Fray Antonio Alcalde" and associated risk factors. To assess the sensitivity of cervical cytology performed in this patient group. Methods: An observational, transversal and descriptive. It is practical thorough colposcopic study 125 women with satisfactory colposcopic study HIV, counts of CD4 + and viral load. Results: normal colposcopic impression: 58.4% did not require biopsy or normal histology: 66.6%, 38 cases of histological abnormalities; LEI low and high grade in 24.8%, 100% correlation between colposcopy and histopathology in cases of invasive carcinoma, VIN and VAIN. It is over-diagnosed low-grade lesions for colposcopy and there was a sub-diagnosis of high-grade lesions, colposcopy disease found in other locations of the lower genital tract as vulvar and perianal condylomata, herpes and molluscum contagiosum. Conclusiones: All women with HIV, regardless of their state of immunosuppression and other risk factors associated with lower genital tract diseases would benefit from routinely undergo a comprehensive colposcopic study.

REFERENCES

1. Williams F.S, Roure R.M, et al. Treatment of cervical carcinoma in situ in HIV positive women. Int J Gynecol & Obstet 2000; 71:135-139

2. Temmerman M, Tyndall M.W, et al. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV infection. Int J Gynecol & Obstet 1999; 65:171-181

3. Suárez AE, Vázquez E, et al. Lesiones escamosas intraepiteliales en pacientes VIH seropositivas. Su frecuencia y asociación con factores de riesgo para neoplasia cervical. Ginecol Obstet Mex 2003;71:32

4. Spinillo A, Tenti P, et al. The influence of Human Immundodeficiency Virus Infection on Langerhans cell counts in the normal cervical tissue. J Acquir Immune Defic Syndr Hum Retrovirol 1996;414-417

5. Quéreux C, Bory JP. HIV, HPV et pathologie cervicale. Contracep Fertil Sex 1997 ;25(2)120-124

6. Levi JE, Fernandes S, et al. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol 2004;92:225-231

7. Spitzer M. Lower genital tract intraepithelial neoplasia in HIV-Infected women: guidelines for evaluation and management. Obstet Gynecol Surv 1999. 54(2)131-137

8. Wright TC, Ellerbrock TV. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994:84:592-597

9. Chiasson MA, Ellerbrock TV, et al. Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstet Gynecol 1997;89:690-4

10. Brown JE, Sunborg M J, et al. Vulvar cancer in human immunodeficiency virus-seropositive premenopausal women: a case series and review of the literature. J Low Genit Tract Dis 2005; 9(1):7-10

11. Lyons F, Prendiville, W, Mulcahy F. Cervical disease in HIV-1 positive women: a review. Int J STD AIDS 2004;89-93

12. Massad LS, Riester K, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. JAIDS 1999;21(1):33-41

13. Matos YF, Costa HLFF. Prevalence of cerical squamous intraepithelial lesions in women with HIV. Int J Gynecol & Obstet 2003;83:63-64

14. Del Mistro A, Chieco Bianchi L. HPV-related neoplasias in HIV-infected individuals. Eur J Cancer 2001;37:1227-1235

15. Palefsky JM et al. Prevalence and risk factors for human papillomavirus infection of the anal canal in humanimmunodeficiency virus (HIV) positive and HIV-negative homosexual men. J infect Dis 1988a;177:361-367

16. Robinson WR, Luck MB, et al. The predictive value of cytologic testing in women with the human immunodeficiency virus who have low-grade squamous cervical lesions : a substudy of a randomizaed, phase III chemoprevention trial. Am J Obstet Gynecol 2003;188:896-900

17. Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 2003;15(5):382-388

18. Branca M, Garbuglia AR, et al. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Int J STD & AIDS 2003;14:417-425